Pierre Fabre Medicament’s MD for Asia Pacific, Ng Tian Wee, on the growing importance of the region for PF, the significance of choosing Singapore as a regional hub, and the company’s strategy moving forward.
In a few words, what is Pierre Fabre’s set up and mandate?
The company is owned by a public-interest organization, the Pierre Fabre Foundation, to which Pierre Fabre donated all of his shares. Its purpose is to improve access to quality drugs and healthcare, with a number of significant projects currently being implemented in several Asian countries such as Vietnam, Laos and Cambodia. To enable the Foundation to fulfill its public-interest mission, it is financed by the company through dividends or grants.
"Over 30 of the top global pharma companies have sited their regional headquarters in Singapore, compared to approximately five in Hong Kong. From a talent pool perspective, Singapore is therefore an ideal location to establish a formidable team spanning the entire value chain of the industry"
